DE1380057U - - Google Patents

Info

Publication number
DE1380057U
DE1380057U DENDAT1380057D DE1380057DU DE1380057U DE 1380057 U DE1380057 U DE 1380057U DE NDAT1380057 D DENDAT1380057 D DE NDAT1380057D DE 1380057D U DE1380057D U DE 1380057DU DE 1380057 U DE1380057 U DE 1380057U
Authority
DE
Germany
Prior art keywords
lun
zur
app
der
ird
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1380057D
Other languages
German (de)
English (en)
Publication of DE1380057U publication Critical patent/DE1380057U/de
Active legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
DENDAT1380057D Active DE1380057U (enExample)

Publications (1)

Publication Number Publication Date
DE1380057U true DE1380057U (enExample)

Family

ID=692473

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1380057D Active DE1380057U (enExample)

Country Status (1)

Country Link
DE (1) DE1380057U (enExample)

Similar Documents

Publication Publication Date Title
Macdonald et al. Interleultin‐2 treatment‐associated eosinophilia is mediated by interleultin‐5 production
CH650003A5 (de) Platin(iv)-diaminkomplexe, verfahren zu deren herstellung und diese enthaltende krebsmittel.
EP0527736A1 (de) Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung.
Ragnhammar et al. Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies
Flynn et al. Production of interleukin-1 and interleukin-2 in allogeneic mixed lymphocyte cultures under copper, magnesium and zinc deficient conditions
WO1991005558A1 (de) Verwendung von lecithin-analoga als antivirale arzneimittel sowie neue verbindungen
CA2274461A1 (en) Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia
US1671868A (en) Mixing or emulsifying process and apparatus
DE3613447A1 (de) 5-pyrimidincarboxamide und ihre verwendung zur behandlung von leukaemie und tumoren
Bicknell Chromosome studies of human brain tumors
Hu et al. The effect of valproic acid on SCE and chromosome aberrations in epileptic children
Sewell et al. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines
DE2854659A1 (de) Neue 3,4-disubstituierte 2-phenylimino-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
KR20150017393A (ko) 인간화된 hiv 감염 동물 모델 및 이의 제조방법
Rüttinger et al. Adjuvante therapeutische Vakzinierung beim Lungenkarzinom: erste Ergebnisse einer klinischen Pilotstudie mit autologer Tumorzell-Impfung nach Lymphopenie-Induktion und Rekonstitution mit autologen T Lymphozyten
Ingalls Musculi sternales and infraclavicularis
Shin et al. Neural signatures of socially shaped self-worth: A meta-analysis
CN215194956U (zh) 一种便于使用的大内科喷雾药器
KNOCK Chemotherapy of human cancer with sulfhydryl inhibitors
DE3730542A1 (de) Arzneimittel mit einem gehalt an bestimmten 6-mercaptopurin-derivaten, verwendung dieser 6-mercaptopurin-derivate, verfahren zur herstellung der arzneimittel sowie einige neue 6-mercaptopurin-derivate und verfahren zu deren herstellung
Koizumi et al. Synergistic induction by calcium ionophore and phorbol ester of interleukin-2 (IL-2) receptor expression, IL-2 production, and proliferation in autoimmune MRL/MP-lpr mice
CN208943869U (zh) 一种对称式进出料混合装置
DE1470381U (enExample)
Goldmann THE PROCESS OF DIGESTION ILLUS-TRATED BY THE ACTION OF STAINS ON THE LIVING TISSUES.
Park et al. Characterization of a T-cell subset prevalent in immunoregulatory disorders in humans